Literature DB >> 23055571

Human cytomegalovirus infection of M1 and M2 macrophages triggers inflammation and autologous T-cell proliferation.

Carina Bayer1, Stefania Varani, Li Wang, Paul Walther, Shaoxia Zhou, Sarah Straschewski, Max Bachem, Cecilia Söderberg-Naucler, Thomas Mertens, Giada Frascaroli.   

Abstract

Macrophages (MΦ) are first targets during human cytomegalovirus (HCMV) infection and are thought to be crucial for viral persistence and dissemination. However, since MΦ are also a first line of defense and key modulators of the immune response, these cells are at the crossroad between protection and viral pathogenesis. To date, the MΦ-specific contribution to the immune response against HCMV is still poorly understood. In view of the opposite roles of M1 and M2 MΦ during initiation and resolution of the immune response, we characterized the effects of HCMV infection on classically activated M1 MΦ and alternatively activated M2 MΦ. Although HCMV susceptibility was higher in M2 MΦ, HCMV established a productive and persistent infection in both types of MΦ. Upon HCMV encounter, both types of MΦ acquired similar features of classical activation and secreted high levels of proinflammatory cytokines and chemokines. As a functional consequence, conditioned media obtained from HCMV-infected M1 and M2 MΦ potently activated freshly isolated monocytes. Finally, compared to HCMV-infected monocyte-derived dendritic cells, infected M1 and M2 MΦ were more efficient in stimulating proliferation of autologous T cells from HCMV-seropositive donors at early times (24 h) postinfection, while the MΦ immunostimulatory properties were reduced, but not abrogated, at later times (72 h postinfection). In summary, our findings indicate that MΦ preserve proper antigen presentation capacity upon HCMV infection while enhancing inflammation, thus suggesting that MΦ play a role in the maintenance of the large HCMV-specific T-cell repertoire in seropositive individuals.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23055571      PMCID: PMC3536399          DOI: 10.1128/JVI.01585-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

Review 1.  Macrophage polarization comes of age.

Authors:  Alberto Mantovani; Antonio Sica; Massimo Locati
Journal:  Immunity       Date:  2005-10       Impact factor: 31.745

2.  Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains.

Authors:  T R Jones; E J Wiertz; L Sun; K N Fish; J A Nelson; H L Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

3.  Macrophage cultures are susceptible to lytic productive infection by endothelial-cell-propagated human cytomegalovirus strains and present viral IE1 protein to CD4+ T cells despite late downregulation of MHC class II molecules.

Authors:  Christian Sinzger; Kathrin Eberhardt; Yolaine Cavignac; Christof Weinstock; Tobias Kessler; Gerhard Jahn; Jean-Luc Davignon
Journal:  J Gen Virol       Date:  2006-07       Impact factor: 3.891

4.  Human cytomegaloviruses expressing yellow fluorescent fusion proteins--characterization and use in antiviral screening.

Authors:  Sarah Straschewski; Martin Warmer; Giada Frascaroli; Heinrich Hohenberg; Thomas Mertens; Michael Winkler
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

5.  Bcl-3-regulated transcription from major immediate-early promoter of human cytomegalovirus in monocyte-derived macrophages.

Authors:  Kashif Aziz Khan; Alain Coaquette; Christian Davrinche; Georges Herbein
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

6.  Quantitative investigation of murine cytomegalovirus nucleocapsid interaction.

Authors:  Christopher Buser; Frank Fleischer; Thomas Mertens; Detlef Michel; Volker Schmidt; Paul Walther
Journal:  J Microsc       Date:  2007-10       Impact factor: 1.758

7.  Human cytomegalovirus paralyzes macrophage motility through down-regulation of chemokine receptors, reorganization of the cytoskeleton, and release of macrophage migration inhibitory factor.

Authors:  Giada Frascaroli; Stefania Varani; Nina Blankenhorn; Robert Pretsch; Michael Bacher; Lin Leng; Richard Bucala; Maria Paola Landini; Thomas Mertens
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

Review 8.  Human cytomegalovirus targets different subsets of antigen-presenting cells with pathological consequences for host immunity: implications for immunosuppression, chronic inflammation and autoimmunity.

Authors:  Stefania Varani; Giada Frascaroli; Maria Paola Landini; Cecilia Söderberg-Nauclér
Journal:  Rev Med Virol       Date:  2009-05       Impact factor: 6.989

9.  Cytomegalovirus-induced immunopathology and its clinical consequences.

Authors:  Stefania Varani; Maria Paola Landini
Journal:  Herpesviridae       Date:  2011-04-07

Review 10.  Bridging fluorescence microscopy and electron microscopy.

Authors:  Ben N G Giepmans
Journal:  Histochem Cell Biol       Date:  2008-06-25       Impact factor: 4.304

View more
  49 in total

1.  Megapinocytosis: a novel endocytic pathway.

Authors:  Andrea Bauer; Narmadha Subramanian; Clarissa Villinger; Giada Frascaroli; Thomas Mertens; Paul Walther
Journal:  Histochem Cell Biol       Date:  2016-01-06       Impact factor: 4.304

2.  Intratumoral Infection with Murine Cytomegalovirus Synergizes with PD-L1 Blockade to Clear Melanoma Lesions and Induce Long-term Immunity.

Authors:  Dan A Erkes; Guangwu Xu; Constantine Daskalakis; Katherine A Zurbach; Nicole A Wilski; Toktam Moghbeli; Ann B Hill; Christopher M Snyder
Journal:  Mol Ther       Date:  2016-06-10       Impact factor: 11.454

Review 3.  Cytomegalovirus immune evasion of myeloid lineage cells.

Authors:  Melanie M Brinkmann; Franziska Dağ; Hartmut Hengel; Martin Messerle; Ulrich Kalinke; Luka Čičin-Šain
Journal:  Med Microbiol Immunol       Date:  2015-03-17       Impact factor: 3.402

4.  Plasminogen Activator Inhibitor-1 Promotes the Recruitment and Polarization of Macrophages in Cancer.

Authors:  Marta Helena Kubala; Vasu Punj; Veronica Rae Placencio-Hickok; Hua Fang; G Esteban Fernandez; Richard Sposto; Yves Albert DeClerck
Journal:  Cell Rep       Date:  2018-11-20       Impact factor: 9.423

5.  Leukotriene B4 promotes neovascularization and macrophage recruitment in murine wet-type AMD models.

Authors:  Fumiyuki Sasaki; Tomoaki Koga; Mai Ohba; Kazuko Saeki; Toshiaki Okuno; Keijiro Ishikawa; Takahito Nakama; Shintaro Nakao; Shigeo Yoshida; Tatsuro Ishibashi; Hamid Ahmadieh; Mozhgan Rezaei Kanavi; Ali Hafezi-Moghadam; Josef M Penninger; Koh-Hei Sonoda; Takehiko Yokomizo
Journal:  JCI Insight       Date:  2018-09-20

6.  Interleukin-2 from Adaptive T Cells Enhances Natural Killer Cell Activity against Human Cytomegalovirus-Infected Macrophages.

Authors:  Zeguang Wu; Giada Frascaroli; Carina Bayer; Tatjana Schmal; Thomas Mertens
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

7.  Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.

Authors:  Zeguang Wu; Ruifang Qin; Li Wang; Matteo Bosso; Myriam Scherer; Thomas Stamminger; Dominik Hotter; Thomas Mertens; Giada Frascaroli
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

8.  Murine Cytomegalovirus Infection of Melanoma Lesions Delays Tumor Growth by Recruiting and Repolarizing Monocytic Phagocytes in the Tumor.

Authors:  Nicole A Wilski; Christina Del Casale; Timothy J Purwin; Andrew E Aplin; Christopher M Snyder
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

9.  One-incubation one-hour multiplex ELISA enabled by aqueous two-phase systems.

Authors:  Mintra Tongdee; Cameron Yamanishi; Midori Maeda; Taisuke Kojima; John Dishinger; Rattikan Chantiwas; Shuichi Takayama
Journal:  Analyst       Date:  2020-05-18       Impact factor: 4.616

10.  Human cytomegalovirus interleukin-10 polarizes monocytes toward a deactivated M2c phenotype to repress host immune responses.

Authors:  Selmir Avdic; John Z Cao; Brian P McSharry; Leighton E Clancy; Rebecca Brown; Megan Steain; David J Gottlieb; Allison Abendroth; Barry Slobedman
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.